期刊文献+

甲巯咪唑与丙硫氧嘧啶治疗Graves甲状腺机能亢进症疗效比较 被引量:33

下载PDF
导出
摘要 目的探讨甲巯咪唑与丙硫氧嘧啶治疗Graves甲状腺机能亢进症(简称甲亢)的临床疗效差异,为Graves甲亢的临床用药提供理论依据。方法选择100例Graves甲亢初诊患者随机分成两组各50例,分别采用剂量相当的甲巯咪唑与丙硫氧嘧啶治疗。于治疗前、治疗第45天、第90天采血检测血清促甲状腺素(TSH)、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺素受体抗体(TRAb)、甲状腺过氧化物酶抗体(TPOAb),比较两组各时间点TSH、FT3、FT4、TRAb、TPOAb水平的差异。结果治疗前两组TSH、FT3、FT4、TRAb、TPOAb水平无统计学差异(P均>0.05)。治疗后与治疗前比较,两组TSH、FT3、FT4、TRAb、TPOAb水平均降低(P均<0.05)。治疗第45天、第90天后丙硫氧嘧啶组FT3、FT4水平均高于甲巯咪唑组(P均<0.01)。治疗后TRAb、TPOAb水平两组间差异无统计学意义(P均>0.05)。结论甲巯咪唑治疗Graves甲亢疗效显著性优于丙硫氧嘧啶。
出处 《山东医药》 CAS 2014年第37期90-92,共3页 Shandong Medical Journal
基金 山东省医药卫生科技发展计划项目(2011HZ052)
  • 相关文献

参考文献8

  • 1Zeugswetter EK, Vogelsinger K, Handl S. Hyperthyroidism in dogs caused by consumption of thyroid-containing head meat [ J ]. Schweiz Arch Tierheilkd, 2013,155 (2) : 149.
  • 2Nakamura H, Noh JY, Itoh K, et al. Comparison of methimazoleand propylthiouracil in patients with hyperthyroidism caused by Graves' disease [ J ]. J Clin Endocrinol Metab, 2007,92 (6) : 2157-2162.
  • 3黎涛.甲巯咪唑与丙硫氧嘧啶治疗Graves'甲状腺机能亢进症疗效观察[J].吉林医学,2013,34(27):5608-5609. 被引量:23
  • 4龙煜.临床药物手册[M].北京:金盾出版社,1994:819-820.
  • 5Komosiuska-Vasssev K, Olczyk K, Kucharz Ej, et, al. Free radical activity and antioxidant defense mechanisms in patients with hyper- thyroidism due to Graves' disease during therapy[ J]. Clin Chim Acta, 2000,300(1-2) :107-117.
  • 6杜洪泉,刘玉,贾爱华,张光珍.丙基硫氧嘧啶与甲巯咪唑对Graves病患者细胞因子的影响[J].中华内分泌代谢杂志,2012,28(9):737-740. 被引量:17
  • 7Cooper DS . Antithyroid drugs [ J ]. N Engl J Med,2005,352 (9) : 905- 917.
  • 8Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis : management guidelines of the A- merican Thyroid Association and American Association of Clinical Endocrinologists[J]. Thyroid, 2011,21(6) :593-646.

二级参考文献26

  • 1Wang SH, Bretz JD, Phelps E, et al. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroidditis. J Immunol, 2002,168:2470-2474.
  • 2Salvi M, Girasole G, Pedrazzoni M, et al. Increased serum concentration of interleukin-6 and soluble IL-6 receptor in patients with Graves′ disease. J Clin Endocrinol Metab, 1996,81:2976-2979.
  • 3Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producting interleukin17. Nat Immunol, 2005,6:1133-1141.
  • 4Allen EM, Bartlett ST. The effect of methimazole iodine and splenocytes on thyroid transplants in BB/Wor rats. Transplantation, 1999,68:25-30.
  • 5Rennie DP, McGregor AM, Keast D, et al. The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology, 1983,112:326-330.
  • 6Cohen SB, Weetman AP. Antithyroid drugs ameliorate thymectomy induced experimental autoimmune thyroiditis. Autoimmunity, 1988,l:51-58.
  • 7Allen EM, Rajatanavin R, Nogimori T, et al. The effect of methimazole on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Am J Med Sci, 1986,292:267-271.
  • 8He CT, Hsieh AT, Pei D, et al. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves′ hyperthyroidism. Clin Endocrinol (Oxf), 2004,60:676-681.
  • 9Wilson R, McKillop JH, Pearson C, et al. Differential immunosup-pressive action of carbimazole and propylthiouracil. Clin Exp Immunol, 1988,73:312-315.
  • 10Hallengren B, Forsgren A, Melander A. Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab, 1980,51:298-301.

共引文献36

同被引文献179

引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部